University of St. Augustine for Health Sciences

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of St. Augustine for Health Sciences sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 3 currently recruiting 3 completed upper quartile by trial count

University of St. Augustine for Health Sciences: 6 sponsored US clinical trials, 3 recruiting.

University of St. Augustine for Health Sciences sponsors 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Spina Bifida, with 1 trials.

Upper-quartile sponsor footprint

University of St. Augustine for Health Sciences sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the University of St. Augustine for Health Sciences pipeline

3 recruiting of 6 indexed (50% open); 3 completed (50%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Spina Bifida (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of St. Augustine for Health Sciences: open-pipeline peers nationwide

Peers matched on 6 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

University of St. Augustine for Health Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 1234567 0%20%40%60%80% Total trials Recruiting share University of St. Augustine for Health Sciences23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan Branch1200 Pharma1ST Biotherapeutics3ive Labs60 Degrees Pharmaceuticals
University of St. Augustine for Health Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of St. Augustine for Health Sciences sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this University of St. Augustine for Health Sciences page

6 registered trials is a research-attention snapshot, not an endorsement of University of St. Augustine for Health Sciences or any single study.

  • 3 of University of St. Augustine for Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Spina Bifida is the condition University of St. Augustine for Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spina Bifida trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of St. Augustine for Health Sciences pipeline card: 6 registered trials from official public datasets.Report a data error.